Determinants of Self-Reported Health Outcomes in Adrenal Insufficiency: A Multi-Site Survey Study.

CONTEXT Current evidence on determinants of adverse health outcomes in patients with adrenal insufficiency (AI) is scarce, especially in regards to AI sub-types. OBJECTIVE To determine predictors of adverse outcomes in different sub-types of AI. DESIGN AND SETTING Cross-sectional survey study at two tertiary centers. PARTICIPANTS 696 patients with AI: primary AI (PAI, 42%), secondary AI (SAI, 32%), and glucocorticoid-induced AI (GIAI, 26%). INTERVENTION Patient-centered questionnaire. MAIN OUTCOME MEASURES Patients' knowledge, self-management of AI, self-perceived health and adverse outcomes. RESULTS The incidence rate of adrenal crisis was 24/100 patient-years with 44% experiencing at least one adrenal crisis since diagnosis (59% in PAI vs 31% in SAI vs 37% in GIAI, p<0.0001). All patients described high degrees of discomfort with self-management and receiving prompt treatment. Patients with PAI were most likely to develop adrenal crises (adjusted OR 2.8, 95% CI: 1.9-4.0) despite reporting better self-perceived health (adjusted OR 3.3, 95% CI: 2.1-5.3), understanding of their diagnosis (89% vs 74-81% in other sub-types, p=0.002), higher comfort with self-management (62% vs 52-61% in other sub-types, p=0.005), and higher likelihood to receive prompt treatment for adrenal crises in the emergency department (42% vs 19-30% in other sub-types, p<0.0001). CONCLUSIONS Patients with AI reported high degrees of discomfort with self-management and treatment delays when presenting with adrenal crises. Despite better self-perceived health and understanding of diagnosis, patients with PAI experienced the highest frequency of adrenal crises. A multi-dimensional educational effort is needed for patients and providers to improve the outcomes of all sub-types of AI.

[1]  L. López-Carrillo,et al.  Non-pharmacological therapies for depressive symptoms in breast cancer patients: Systematic review and meta-analysis of randomized clinical trials. , 2019, Breast.

[2]  S. Hahner Acute adrenal crisis and mortality in adrenal insufficiency: Still a concern in 2018! , 2018, Annales d'endocrinologie.

[3]  J. Jung,et al.  Non-pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome. , 2018, The Cochrane database of systematic reviews.

[4]  K. Badenhoop,et al.  Longitudinal AddiQoL scores may identify higher risk for adrenal crises in Addison’s disease , 2018, Endocrine.

[5]  J. Bertherat,et al.  Group 1. Epidemiology of primary and secondary adrenal insufficiency: Prevalence and incidence, acute adrenal insufficiency, long-term morbidity and mortality. , 2017, Annales d'endocrinologie.

[6]  S. Salvioli,et al.  The effectiveness of conservative, non-pharmacological treatment, of plantar heel pain: A systematic review with meta-analysis. , 2017, Foot.

[7]  G. Johannsson,et al.  Health Care Burden in Patients With Adrenal Insufficiency , 2017, Journal of the Endocrine Society.

[8]  R. Murray,et al.  Management of glucocorticoid replacement in adrenal insufficiency shows notable heterogeneity – data from the EU‐AIR , 2017, Clinical endocrinology.

[9]  K. White,et al.  Addison’s forum helps to support and engage patients , 2016, British Medical Journal.

[10]  G. Johannsson,et al.  Exploring Inpatient Hospitalizations and Morbidity in Patients With Adrenal Insufficiency. , 2016, The Journal of clinical endocrinology and metabolism.

[11]  W. Dixon,et al.  Systemic glucocorticoid therapy and adrenal insufficiency in adults: A systematic review , 2016, Seminars in arthritis and rheumatism.

[12]  Stefan R Bornstein,et al.  Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline. , 2016, The Journal of clinical endocrinology and metabolism.

[13]  P. Zelissen,et al.  Incidence of adrenal crisis in patients with adrenal insufficiency , 2016, Clinical endocrinology.

[14]  F. Beuschlein,et al.  Timelines in the management of adrenal crisis – targets, limits and reality , 2015, Clinical endocrinology.

[15]  S. Hahner,et al.  Diagnosis and management of adrenal insufficiency. , 2015, The lancet. Diabetes & endocrinology.

[16]  M. Faber,et al.  The Contribution of Online Peer-to-Peer Communication Among Patients With Adrenal Disease to Patient-Centered Care , 2015, Journal of medical Internet research.

[17]  F. Beuschlein,et al.  High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study. , 2015, The Journal of clinical endocrinology and metabolism.

[18]  A. Kaptein,et al.  Quality of life (QoL) impairments in patients with a pituitary adenoma: a systematic review of QoL studies , 2015, Pituitary.

[19]  H. Repping-Wuts,et al.  A glucocorticoid education group meeting: an effective strategy for improving self-management to prevent adrenal crisis. , 2013, European journal of endocrinology.

[20]  M. den Heijer,et al.  Impaired quality of life in patients in long-term remission of Cushing's syndrome of both adrenal and pituitary origin: a remaining effect of long-standing hypercortisolism? , 2012, European journal of endocrinology.

[21]  K. Badenhoop,et al.  Quality of life in European patients with Addison's disease: validity of the disease-specific questionnaire AddiQoL. , 2012, The Journal of clinical endocrinology and metabolism.

[22]  S. Hahner,et al.  Delayed Diagnosis of Adrenal Insufficiency Is Common: A Cross-Sectional Study in 216 Patients , 2010, The American journal of the medical sciences.

[23]  O. Decker,et al.  Influence of hydrocortisone dosage scheme on health‐related quality of life in patients with adrenal insufficiency , 2010, Clinical endocrinology.

[24]  M. Fassnacht,et al.  Epidemiology of adrenal crisis in chronic adrenal insufficiency: the need for new prevention strategies. , 2010, European journal of endocrinology.

[25]  J. Carlson,et al.  Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry. , 2009, The Journal of clinical endocrinology and metabolism.

[26]  P. Harris,et al.  Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.

[27]  J. Svartberg,et al.  Normal overall mortality rate in Addison's disease, but young patients are at risk of premature death. , 2008, European journal of endocrinology.

[28]  M. Fassnacht,et al.  Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross-sectional analysis. , 2007, The Journal of clinical endocrinology and metabolism.

[29]  J. Romijn,et al.  Quality of life in patients after long-term biochemical cure of Cushing's disease. , 2005, The Journal of clinical endocrinology and metabolism.

[30]  C. Polychronakos,et al.  Prednisolone in the treatment of adrenal insufficiency: a re-evaluation of relative potency. , 2003, The Journal of pediatrics.

[31]  E. Husebye,et al.  Subjective health status in Norwegian patients with Addison’s disease * , 2002, Clinical endocrinology.

[32]  P. Zelissen,et al.  Associated autoimmunity in Addison's disease. , 1995, Journal of autoimmunity.

[33]  A. Moreira,et al.  Adrenocortical dysfunction in paracoccidioidomycosis: comparison between plasma β‐lipotrophin/adrenocorticotrophin levels and adrenocortical tests , 1992, Clinical endocrinology.

[34]  B. Czarnocka,et al.  Association of Addison's disease with autoimmune disorders--a long-term observation of 180 patients. , 1991, Postgraduate medical journal.